ZRG17 Antibody

What is ZRG17 and what is its primary function?

ZRG17 is a zinc transporter protein in yeast that forms a complex with Msc2 to transport zinc into the early secretory pathway compartments, including the endoplasmic reticulum (ER) and Golgi apparatus. This transport is essential for proper functioning of zinc-dependent proteins in these compartments, including enzymes, chaperones, and other proteins involved in secretory pathway processes . The Zrg17/Msc2 complex appears to be the primary mechanism for transporting zinc into these compartments, and disruption of this function can lead to ER stress and trigger the Unfolded Protein Response (UPR) .

How is ZRG17 regulated in response to zinc levels?

ZRG17 expression is regulated at the transcriptional level by Zap1, a zinc-responsive transcription factor. Under zinc-limited conditions, Zap1 binds to a specific Zinc-Responsive Element (ZRE) in the ZRG17 promoter, located approximately 66 to 55 base pairs upstream of the transcription start site, and induces gene expression . This regulatory mechanism ensures that ZRG17 levels increase during zinc deficiency, when there is a greater need for efficient zinc transport into the secretory pathway.

The regulation involves two components:

• Basal, Zap1-independent expression that occurs under zinc-replete conditions

• Zap1-dependent induction that increases expression approximately 2-3 fold during zinc limitation

Protein levels of Zrg17 correlate well with mRNA levels, indicating that transcriptional control is the primary mechanism for regulating Zrg17 abundance .

What experimental approaches can verify ZRG17 antibody specificity?

To verify ZRG17 antibody specificity, researchers should implement multiple validation strategies:

• Western blot with positive and negative controls: Compare wild-type yeast strains expressing ZRG17 with zrg17Δ mutant strains. A specific antibody will show a band of the expected molecular weight (~37 kDa) in wild-type samples but not in deletion mutants .

• Epitope-tagged protein expression: Express an epitope-tagged version of ZRG17 (e.g., HA-tagged ZRG17) and perform parallel detection with both anti-ZRG17 and anti-epitope antibodies. Co-localization of signals confirms specificity .

• Immunoprecipitation validation: Perform immunoprecipitation with the ZRG17 antibody followed by mass spectrometry identification or Western blotting to confirm target protein identity.

• RNA interference approaches: Analyze antibody reactivity in samples where ZRG17 has been knocked down using RNA interference techniques compared to control samples.

What are the optimal conditions for immunodetection of ZRG17 protein?

For optimal immunodetection of ZRG17 protein in yeast samples:

• Protein extraction method: Trichloroacetic acid (TCA) precipitation provides effective protein extraction from yeast cells and helps preserve post-translational modifications of ZRG17 .

• Sample preparation: When analyzing zinc-dependent expression, culture cells in controlled zinc environments such as Low Zinc Medium (LZM) supplemented with varying zinc concentrations (0-100 μM ZnCl₂) .

• Loading controls: Use constitutively expressed proteins such as Pgk1 (3-phosphoglycerate kinase) as loading controls for immunoblotting experiments .

• Detection method: For HA-tagged ZRG17, anti-HA antibodies (such as 12CA5 from Roche Applied Science) provide reliable detection, with HRP-conjugated goat anti-mouse IgG as a secondary antibody .

• Quantification: Use software such as NIH ImageJ for band intensity measurement and accurate quantification of relative protein levels .

How can researchers detect ZRG17 mRNA expression levels?

For accurate detection of ZRG17 mRNA expression:

• RNA extraction: Extract total RNA from yeast cells grown to mid-log phase using hot acid phenol extraction method .

• S1 nuclease protection assay: This method provides sensitive and specific detection of ZRG17 mRNA. For each reaction:

  • Use 15 μg of total RNA

  • Hybridize with 32P-end-labeled DNA oligonucleotide probes specific for ZRG17

  • Include CMD1 (calmodulin) as a non-zinc-responsive control gene

  • Perform digestion with S1 nuclease

  • Separate on a 10% polyacrylamide, 5 M urea gel

  • Quantify band intensities using phosphorimager analysis

• RT-qPCR: As an alternative method, design primers specific to the ZRG17 coding sequence for quantitative PCR analysis.

• Promoter-reporter constructs: For studying transcriptional regulation, construct ZRG17 promoter-lacZ fusions to measure promoter activity under different zinc conditions .

What experimental approaches can determine if ZRG17 function is impaired?

Several phenotypic assays can indirectly assess ZRG17 function:

• Growth assays under stress conditions: Test growth at elevated temperatures (37°C) on glycerol/ethanol-containing media (YPGE). ZRG17-deficient strains show growth defects under these conditions that can be rescued by zinc supplementation .

• ER stress measurement: Use a UPRE-lacZ reporter construct to measure Unfolded Protein Response activation. ZRG17-deficient strains show elevated UPR activation under zinc-limited conditions, indicating ER dysfunction .

• Zinc-dependent enzyme activity: Measure the activity of zinc-dependent enzymes in the secretory pathway as functional readouts of zinc transport.

• Genetic interaction studies: Test genetic interactions with other components of zinc homeostasis (e.g., zap1Δ, msc2Δ) to assess functional relationships.

How can researchers examine the Zap1-ZRG17 promoter interaction in vivo?

To investigate Zap1 binding to the ZRG17 promoter in vivo:

• Chromatin immunoprecipitation (ChIP):

  • Culture cells under low zinc conditions

  • Cross-link protein-DNA complexes with 1% formaldehyde

  • Isolate and shear chromatin by sonication

  • Immunoprecipitate Zap1 (using epitope-tagged Zap1 and corresponding antibody)

  • Reverse cross-links and assess co-immunoprecipitation of ZRG17 promoter fragments by PCR

  • Include positive controls (known Zap1 targets like ZRT1) and negative controls (non-zinc responsive genes like CMD1)

• Site-directed mutagenesis of the ZRE:

  • Create mutations in the Zinc-Responsive Element in the ZRG17 promoter

  • Assess effects on ZRG17 expression using reporter constructs

  • Compare wild-type and mutant promoters under varying zinc conditions

The following table shows oligonucleotides used for creating ZRE mutations:

Note: The ZRE sequence or mutated region is underlined in each complementary oligonucleotide pair. Lower-case letters indicate restriction enzyme-compatible overhangs used for cloning.

How can researchers distinguish between transcriptional and post-translational regulation of ZRG17?

To differentiate between different regulatory mechanisms:

• Correlation analysis: Compare mRNA levels (by S1 nuclease protection assay or RT-qPCR) with protein levels (by immunoblotting) across a range of zinc concentrations. Consistent correlation suggests transcriptional control as the primary mechanism .

• Constitutive expression systems: Express ZRG17 from a constitutive, non-zinc-responsive promoter and assess protein levels under different zinc conditions. Changes in protein levels would indicate post-translational regulation.

• Protein stability assays: Perform cycloheximide chase experiments to assess ZRG17 protein stability under different zinc conditions.

• Phosphorylation analysis: Since ZRG17 is known to be phosphorylated in vivo, use phosphatase treatments before immunoblotting to assess the contribution of phosphorylation to regulation .

• Mass spectrometry: Use quantitative proteomic approaches to identify and quantify post-translational modifications of ZRG17 under different conditions.

How can researchers assess the biological importance of ZRG17 regulation in zinc homeostasis?

To evaluate the biological significance of ZRG17 regulation:

• Targeted promoter mutation: Replace the ZRE in the chromosomal ZRG17 gene with a non-functional sequence (like the m2ZRE mutant) to specifically disrupt Zap1-mediated regulation while maintaining basal expression .

• Phenotypic analysis: Compare wild-type, zrg17Δ, and ZRE-mutant strains using:

  • Growth assays under various stress conditions

  • UPRE-lacZ reporter to assess ER stress levels

  • Zinc-dependent enzyme activities

• Zinc supplementation experiments: Test whether phenotypes of regulatory mutants can be rescued by zinc supplementation, which would bypass the need for regulated transport.

• Systems biology approach: Integrate transcriptomic and proteomic data to model how ZRG17 regulation fits within the broader zinc homeostasis network.

What are common challenges in detecting ZRG17 protein and how can they be addressed?

Common challenges and solutions include:

• Low protein abundance:

  • Use enrichment techniques like immunoprecipitation before detection

  • Employ more sensitive detection methods like chemiluminescence

  • Consider using epitope-tagged versions of ZRG17 for better antibody detection

• Cross-reactivity issues:

  • Perform thorough validation using knockout controls

  • Use peptide competition assays to confirm specificity

  • Optimize blocking conditions to reduce background

• Post-translational modifications:

  • Be aware that phosphorylation may alter protein migration patterns

  • Consider using phosphatase treatments to assess the impact of phosphorylation on detection

• Membrane protein extraction challenges:

  • Use detergent-based extraction methods optimized for membrane proteins

  • Consider using specialized membrane protein extraction kits

How should researchers interpret ZRG17 expression data in different genetic backgrounds?

When interpreting ZRG17 expression data:

• Wild-type vs. zap1Δ strains: In wild-type cells, ZRG17 mRNA levels increase ~2-fold under zinc limitation, but this induction is absent in zap1Δ mutants. This confirms Zap1-dependent regulation .

• ZRE mutant strains: Mutations in the ZRE element abolish zinc-responsive induction but do not affect basal expression in zinc-replete conditions, indicating separate regulatory mechanisms for basal and induced expression .

• Constitutive Zap1 expression: When constitutive Zap1 (Zap1up) is expressed in zinc-replete cells, ZRG17 mRNA levels increase ~3-fold, confirming direct Zap1 regulation .

• Correlation with phenotypes: The zrg17-1 m2ZRE mutant (with normal basal expression but defective induced expression) shows intermediate phenotypes between wild-type and complete deletion mutants, indicating that both basal and induced expression contribute to function .

• Consider genetic background effects: Different yeast strain backgrounds may show variations in the magnitude of zinc responsiveness.

How can researchers design experiments to study the ZRG17-Msc2 complex formation?

To study the ZRG17-Msc2 complex:

• Co-immunoprecipitation studies:

  • Express epitope-tagged versions of both proteins (e.g., ZRG17-HA and Msc2-Myc)

  • Perform immunoprecipitation with one tag antibody

  • Detect the partner protein by immunoblotting with the other tag antibody

  • Include appropriate controls (single-tagged strains, non-specific antibodies)

• Bimolecular Fluorescence Complementation (BiFC):

  • Fuse complementary fragments of a fluorescent protein to ZRG17 and Msc2

  • Interaction brings the fragments together to reconstitute fluorescence

  • Visualize complex formation by fluorescence microscopy

• Förster Resonance Energy Transfer (FRET):

  • Tag ZRG17 and Msc2 with compatible fluorophores

  • Measure energy transfer between the fluorophores as an indication of protein proximity

• Genetic interaction studies:

  • Compare phenotypes of zrg17Δ, msc2Δ, and zrg17Δ msc2Δ double mutants

  • Epistatic relationships suggest functional interactions

• Structure-function analysis:

  • Create targeted mutations in potential interaction domains

  • Assess effects on complex formation and function

How does ZRG17 compare to zinc transporters in higher eukaryotes?

ZRG17 and its regulation can be compared to mammalian zinc transporters:

• Functional homology:

  • The yeast Zrg17/Msc2 complex appears functionally homologous to mammalian zinc transporters in the secretory pathway, including heterodimeric ZnT-5/ZnT-6 and homodimeric ZnT-7 .

• Regulatory similarities:

  • Like ZRG17, both ZnT-5 and ZnT-7 mRNA levels increase in zinc-limited mammalian cells .

  • ZnT-5 regulation involves both transcriptional control and mRNA stability mechanisms, with increased promoter activity in zinc-limited cells .

• Structural conservation:

  • Functional analysis of conserved domains could reveal evolutionarily preserved mechanisms of zinc transport.

• Physiological roles:

  • In both yeast and mammalian systems, these transporters supply zinc to secretory pathway compartments where numerous zinc-dependent proteins function.

What methodological differences exist between studying ZRG17 in yeast versus mammalian zinc transporters?

Key methodological considerations for comparative studies:

• Model system advantages:

  • Yeast offers genetic tractability, simpler culture conditions, and faster generation time

  • Mammalian systems provide greater relevance to human biology and disease

• Technical approaches:

  • Yeast studies often utilize S1 nuclease protection assays for mRNA quantification, while mammalian studies typically employ RT-qPCR or RNA-Seq

  • Knockout generation is straightforward in yeast using homologous recombination, while mammalian studies may require CRISPR/Cas9 or other technologies

• Functional assays:

  • Yeast studies can use growth phenotypes and UPR activation as functional readouts

  • Mammalian studies may employ cell type-specific assays related to specialized functions (e.g., insulin secretion in pancreatic β-cells)

• Experimental timeline:

  • Yeast experiments can be completed in days, whereas mammalian studies often require weeks or months

  • This difference impacts experimental design and iteration speed